Safety and Efficacy of Sitagliptin compared with Glimepiride in Patients with Type 2 Diabetes Mellitus inadequately controlled with Metfromin Monotherapy
Year: 2013
Type: article
Study design: Clinical Trial
Abstract: Background: Type 2 diabetes mellitus (DM) is a life-long disease requiring chronic treatment and management. Therefore, assessment of the long-term safety and tolerability of newer therapeutic agents is of importance. Objective: To compare safety and efficacy of sitagliptin with glimepiride in patients with type 2 diabetes mellitus not adequately controlled with metformin monotherapy. Method: This study was conducted at Pharmacology Department, Gomal Medical College, Dera Ismail Khan from 1st June 2010 to 31st December 2012. Patients of type 2 DM not adequately controlled with a stable dose of metformin (≥ 1500 mg/day) monotherapy were randomized into 02 groups. One group was given sitagliptin 100mg while other group was given glimepiride 2mg once daily for 12 weeks. Primary end point of the study was number of patients achieving the target HbA1C
Authors: Amjad Abrar, Shimal Khan, Mehboob ur Rehman, Tehmina Jan, Muhammad Faisal
Institutions: Gomal University, Pakistan Institute of Medical Sciences
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1939212295
